港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫美概念股

686.108

-31.133-4.34%

漲家數：4

跌家數：6

平家數：3

市盈率：- -

高：696.344

開：678.885

低：675.692

收：717.241

資料載入中...

康哲藥業04月22日獲主力加倉829萬元

時代天使04月22日獲主力加倉17萬元

時代天使股東李華敏收購上海愷皓40%股權關聯關係確立

復星醫藥，增持復宏漢霖至63.43%

國信證券：關注出海加速的創新藥以及政策支持的服務板塊

復宏漢霖盤中漲超9% 復星醫藥擬5.17億港元增持復宏漢霖3.87%股權

港股異動 | 復宏漢霖(02696)再漲超9% 復星醫藥擬5.17億港元增持復宏漢霖3.87%股權

瑞麗醫美股價飆升10.91% 市值漲741.44萬港元

港股異動 | 三生製藥(01530)漲超3% 抗VEGF/PD-1雙特異性抗體獲國家藥監局突破性療法認定

康哲藥業盤中異動早盤股價大漲5.31%

三生製藥盤中異動早盤大幅上漲6.52%報12.740港元

【灣區早參】復活節假期香港出入境人次逾432萬；深圳入選全國二手商品流通試點城市

擬被複星醫藥超5億增持的復宏漢霖，想在海外市場大展拳腳

復星醫藥：擬5.17億港元增持控股子公司復宏漢霖3.87%股權

復星醫藥擬5.17億增持復宏漢霖3.87%股份

復星醫藥獲融資買入0.11億元，近三日累計買入0.59億元

康哲藥業2024年淨利降超30% 高管逆勢漲薪

每日賣空追蹤 | 三生製藥 04月17日賣空量成交127.3萬股，賣空比例為4.45%

現代牙科(03600)4月17日斥資42.02萬港元回購10萬股

三生製藥抗癌新藥被納入突破性治療品種

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1593/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":686.1075,"timestamp":1745827736034,"preClose":717.24054,"halted":0,"volume":158238758,"delay":0,"changeRate":-0.043407,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-31.133057,"latestTime":"04-28 16:00:00","open":678.8851,"high":696.34436,"low":675.6922,"amount":1315776884,"amplitude":0.028794,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745890200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745803800000,1745812800000],[1745816400000,1745827200000]],"pbRate":1.255448,"peRate":19.315719,"turnoverRate":0.007817,"increases":3,"decrements":7,"flats":3,"marketCap":118158594152,"floatMarketCap":82270515368},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":696.34436,"amplitude":0.028794,"preClose":717.24054,"low":675.6922,"pbRate":"1.255448","latestPrice":686.1075,"volume":158238758,"delay":0,"open":678.8851,"prevYearClose":571.87146,"prevWeekClose":717.241,"prevMonthClose":677.607,"prevQuarterClose":677.607,"fiveDayClose":661.02,"twentyDayClose":662.617,"sixtyDayClose":538.937,"secType":"PLATE","market":"HK","turnoverRate":0.007817,"peRate":19.315719,"marketCap":118158594152,"floatMarketCap":82270515368,"timestamp":1745827736034,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":4,"down":6,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529831321","title":"康哲藥業04月22日獲主力加倉829萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529831321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529831321?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 16:16","pubTimestamp":1745309765,"startTime":"0","endTime":"0","summary":"04月22日, 康哲药业股价涨10.75%，报收8.14元，成交金额1.14亿元，换手率0.58%，振幅12.24%，量比1.74。康哲药业今日主力资金净流入829万元，上一交易日主力净流入153万元。该股近5个交易日上涨9.82%，主力资金累计净流入1460万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入5460万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171027a4623a7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171027a4623a7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BYV24P56.USD","SG9999015986.USD","LU2488822045.USD","SG9999015978.USD","IE00BMCWC346.EUR","SG9999015952.SGD","00867","BK1191","SG9999004220.SGD","SG9999015945.SGD","BK1593"],"gpt_icon":0},{"id":"2529256943","title":"時代天使04月22日獲主力加倉17萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529256943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529256943?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 16:15","pubTimestamp":1745309722,"startTime":"0","endTime":"0","summary":"04月22日, 时代天使股价涨4.59%，报收48.95元，成交金额4137万元，换手率0.50%，振幅5.13%，量比1.34。时代天使今日主力资金净流入17万元，上一交易日主力净流入52万元。该股近5个交易日上涨1.88%，主力资金累计净流出682万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1935万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422170609a6c389fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422170609a6c389fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1593","06699","BK1583","BK1587"],"gpt_icon":0},{"id":"2529310883","title":"時代天使股東李華敏收購上海愷皓40%股權 關聯關係確立","url":"https://stock-news.laohu8.com/highlight/detail?id=2529310883","media":"财中社","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529310883?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 14:52","pubTimestamp":1745304755,"startTime":"0","endTime":"0","summary":"4月22日，时代天使（06699）发布公告，上海恺皓已成为公司的关联人士，原因是公司主要股东李华敏已收购上海恺皓总股权的40%。因此，上海恺皓与公司之间的加工承包协议项下的持续交易已成为公司的持续关联交易。根据上市规则第14A.60条，公司需遵守年度审阅及披露规定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504223384285745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06699","BK1100","BK1587","BK1593","BK1583"],"gpt_icon":0},{"id":"2529124313","title":"復星醫藥，增持復宏漢霖至63.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529124313","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529124313?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 13:03","pubTimestamp":1745298180,"startTime":"0","endTime":"0","summary":"　　复星医药发公告指，上周四斥资3.68亿港元增持复宏汉霖约1494.07万股非上市股份，平均每股作价24.6港元，卖方为生物科技投资公司HenLink。　　复星医药又在4月15日与舟山果运签订股份转让协议，向对方收购138.12万股复宏汉霖非上市股份，每股代价为24.6港元，涉3397.75万港元。　　上述数项交易完成后，复星医药持有复宏汉霖股权比例会由59.56%增加至63.43%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-22/doc-inetzkuw4200955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02196","BK0183","02696","BK0096","BK0012","BK1191","BK1515","BK0188","BK0175","600196","BK0187","BK1161","BK0196","BK0060","BK0028","BK0239","BK1593"],"gpt_icon":0},{"id":"2529394377","title":"國信證券：關注出海加速的創新藥以及政策支持的服務板塊","url":"https://stock-news.laohu8.com/highlight/detail?id=2529394377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529394377?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 11:00","pubTimestamp":1745290808,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国信证券发布研报称，从2025年初以来，国产创新药企业已经完成了几十笔对外授权的交易，均与海外MNC达成了重磅交易。国产创新药的研发进度和临床数据越来越在全球范围内占到优势，创新药BD出海受关税影响较小，有望继续通过授权出海的形式实现全球的商业化价值。报告中称，2025年4月10日，国家医保局正式宣告中国医疗保险研究会生育保险专业委员会成立。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0417516571.SGD","BK1588","LU1794554557.SGD","IE00BPRC5H50.USD","06990","LU0348783233.USD","LU1720050803.USD","BK0183","BK0188","BK1161","BK0028","09926","BK1574","06978","BK1191","00013","LU0348784397.USD","BK1593","159992","LU2488822045.USD","01530","IE00B543WZ88.USD","BK1587","02162","BK0276","LU0196878994.USD","IE00B5MMRT66.SGD","BK1583","002736"],"gpt_icon":0},{"id":"2529395970","title":"復宏漢霖盤中漲超9% 復星醫藥擬5.17億港元增持復宏漢霖3.87%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2529395970","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529395970?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 10:42","pubTimestamp":1745289720,"startTime":"0","endTime":"0","summary":"　　复宏汉霖盘中涨超9%，截至发稿，股价上涨8.40%，现报36.80港元，成交额3593.75万港元。　　消息面上，复星医药公布，今年4月11日至17日期间，控股子公司复星医药产业与上海善梧、无锡通善、舟山果运及Henlink分别签订转让协议，控股子公司复星医药产业拟以24.60港元/股的价格受让上海善梧、无锡通善、舟山果运及Henlink合计持有的2103万股复宏汉霖非上市股份，转让价款共计5.17亿港元。在此次增持之后，复星医药持有复宏汉霖的股权比例将增至63.43%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetzepa1054800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0196","BK0028","BK1593","BK1191","BK0060","BK0183","02196","BK0187","BK0096","BK1161","BK0188","BK1515","BK0239","BK0175","600196","02696"],"gpt_icon":0},{"id":"2529393265","title":"港股異動 | 復宏漢霖(02696)再漲超9% 復星醫藥擬5.17億港元增持復宏漢霖3.87%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2529393265","media":"智通财经","labels":["shareholding","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529393265?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 10:32","pubTimestamp":1745289125,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复宏汉霖再涨超9%，截至发稿，涨8.54%，报36.85港元，成交额3528.23万港元。消息面上，复星医药公布，今年4月11日至17日期间，控股子公司复星医药产业与上海善梧、无锡通善、舟山果运及Henlink分别签订转让协议，控股子公司复星医药产业拟以24.60港元/股的价格受让上海善梧、无锡通善、舟山果运及Henlink合计持有的2103万股复宏汉霖非上市股份，转让价款共计5.17亿港元。在此次增持之后，复星医药持有复宏汉霖的股权比例将增至63.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK1593","BK0239","BK0060","02696","BK0012","BK1191","BK0187","BK0028","BK1161","BK0183","BK0196","BK1515","BK0175","BK0096","02196","600196"],"gpt_icon":0},{"id":"2529398099","title":"瑞麗醫美股價飆升10.91% 市值漲741.44萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529398099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529398099?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 10:15","pubTimestamp":1745288144,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘10时15分，瑞丽医美股票出现波动，股价急速拉升10.91%。截至发稿，该股报0.122港元/股，成交量4万股，换手率0.01%，振幅0.00%。瑞丽医美股票所在的医疗及医学美容服务行业中，整体跌幅为0.06%。其相关个股中，艾迪康控股、美中嘉和、瑞丽医美涨幅较大，振幅较大的相关个股有艾迪康控股、美中嘉和、一脉阳光，振幅分别为51.69%、42.00%、7.80%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422101544a461cf7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422101544a461cf7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02135","BK1593","BK1209"],"gpt_icon":0},{"id":"2529436787","title":"港股異動 | 三生製藥(01530)漲超3% 抗VEGF/PD-1雙特異性抗體獲國家藥監局突破性療法認定","url":"https://stock-news.laohu8.com/highlight/detail?id=2529436787","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529436787?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 09:46","pubTimestamp":1745286407,"startTime":"0","endTime":"0","summary":"消息面上，三生制药发布公告，该公司自主研发的抗VEGF/PD-1双特异性抗体于2025年4月17日获国家药品监督管理局纳入突破性治疗品种，适应症为一线治疗PD-L1表达阳性的局部晚期或转移性非小细胞肺癌。据介绍，707注射液是三生制药基于CLF2专利平台自主开发的靶向VEGF/PD-1双特异性抗体，目前正于中国开展多项临床研究，其中一线治疗PD-L1表达阳性的局部晚期或转移性非小细胞肺癌已获国家药监局药品审评中心批准开展III期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4023","BK1593","01530","LU1169590202.USD","BK1583","BK1161","PD","LU1169589451.USD"],"gpt_icon":0},{"id":"2529836034","title":"康哲藥業盤中異動 早盤股價大漲5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529836034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529836034?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 09:34","pubTimestamp":1745285689,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时34分，康哲药业股票出现异动，股价急速上涨5.31%。截至发稿，该股报7.740港元/股，成交量65.8619万股，换手率0.03%，振幅5.31%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康哲药业股票所在的药品行业中，整体涨幅为0.24%。其相关个股中，三生制药、远大医药、石药集团涨幅较大，振幅较大的相关个股有石药集团、和黄医药、远大医药，振幅分别为7.19%、6.33%、6.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093449973ff82c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093449973ff82c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867","BK1593","LU2488822045.USD","SG9999015986.USD","IE00BYV24P56.USD","BK1191","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999015978.USD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2529636248","title":"三生製藥盤中異動 早盤大幅上漲6.52%報12.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529636248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529636248?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 09:30","pubTimestamp":1745285411,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时30分，三生制药股票出现异动，股价急速拉升6.52%。截至发稿，该股报12.740港元/股，成交量59万股，换手率0.02%，振幅3.01%。资金方面，该股资金流入379.414万港元，流出52.754万港元。三生制药股票所在的药品行业中，整体涨幅为0.20%。其相关个股中，三生制药、信达生物、凯莱英涨幅较大，振幅较大的相关个股有凯莱英、三生制药、德琪医药-B，振幅分别为2.90%、2.51%、1.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093011973ff6c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093011973ff6c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1593","BK1161"],"gpt_icon":0},{"id":"2529363740","title":"【灣區早參】復活節假期香港出入境人次逾432萬；深圳入選全國二手商品流通試點城市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529363740","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529363740?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 08:26","pubTimestamp":1745281568,"startTime":"0","endTime":"0","summary":"18日香港复活节假期首日，共有近125万人次经各口岸出入境，其中入境约41.8万人次，出境约83.2万人次，迎来出境高峰。出境人次中，香港居民为72.4万人次，大批香港居民选择赴内地度假。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1957441","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","CFA.SI","LU2460026573.USD","BK1615","LU1115378108.SGD","00780","BK1516","03606","BK1583","BK1544","IE0034224299.USD","BK1178","06936","BK1592","LU0572944931.SGD","BK1538","BK1198","BK1191","SG9999001226.SGD","02196","LU1655091616.SGD","LU0456827905.SGD","02696","BK1133","LU0828238088.HKD","01818","00656","LU0278937759.USD","LU0327786744.USD","LU0315179316.USD","SG9999002463.SGD","SGXZ90724238.SGD","BK1506","BK1509","SG9999001093.SGD","LU0051755006.USD","01898","BK1144","LU0269904917.USD","BK1604","SG9999001051.SGD","BK1230","LU0455707207.USD","01171","00762","LU0502904849.HKD","BK1151","BK1554","LU0640798160.USD","BK1593"],"gpt_icon":0},{"id":"2529836063","title":"擬被複星醫藥超5億增持的復宏漢霖，想在海外市場大展拳腳","url":"https://stock-news.laohu8.com/highlight/detail?id=2529836063","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529836063?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 22:39","pubTimestamp":1745246343,"startTime":"0","endTime":"0","summary":"本次增持完成后，复星医药持有复宏汉霖的股权比例将增至63.43%。2024年6月24日，复星医药抛出了一则关于拟以不超过约54.07亿港元私有化复宏汉霖计划。不过，在今年1月复宏汉霖股票大会投票中，该计划未能获得通过，导致私有化方案搁浅。在国内市场竞争激烈的背景下，拓展海外市场是很多创新药企追逐的梦想，复宏汉霖正试图在海外市场大展拳脚。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223914a6c282a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223914a6c282a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02696","02196","BK1191","BK1161","BK1515"],"gpt_icon":0},{"id":"2529772822","title":"復星醫藥：擬5.17億港元增持控股子公司復宏漢霖3.87%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2529772822","media":"人民财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529772822?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 16:48","pubTimestamp":1745225291,"startTime":"0","endTime":"0","summary":"复星医药：拟5.17亿港元增持控股子公司复宏汉霖3.87%股权","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504213382987043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02696","BK1191","02196","BK1515","BK1593"],"gpt_icon":0},{"id":"2529784198","title":"復星醫藥擬5.17億增持復宏漢霖3.87%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2529784198","media":"观点网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529784198?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 16:33","pubTimestamp":1745224380,"startTime":"0","endTime":"0","summary":"观点网讯：4月21日，复星医药发布关于增持控股子公司股权的提示性公告。复星医药拟以自筹资金支付本次增持对价。本次增持完成后，复星医药持有复宏汉霖的股权比例将增至63.43%。由于复星医药执行董事关晓晖女士兼任无锡通善之间接控股股东HermedCapital之董事，根据上证所《上市规则》，无锡通善构成本公司的关联方，本次增持中，复星医药产业受让无锡通善持有之4,666,667股复宏汉霖非上市股份构成本公司的关联交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042116392394dca9d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042116392394dca9d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","02196","02696","BK1191","BK1593"],"gpt_icon":1},{"id":"2528488049","title":"復星醫藥獲融資買入0.11億元，近三日累計買入0.59億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528488049","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528488049?lang=zh_tw&edition=fundamental","pubTime":"2025-04-19 08:02","pubTimestamp":1745020955,"startTime":"0","endTime":"0","summary":"4月18日，沪深两融数据显示，复星医药获融资买入额0.11亿元，居两市第716位，当日融资偿还额0.24亿元，净卖出1238.86万元。最近三个交易日，16日-18日，复星医药分别获融资买入0.18亿元、0.30亿元、0.11亿元。融券方面，当日融券卖出0.01万股，净买入0.56万股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/19080249677943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0096","BK0196","BK0239","BK1191","BK0175","BK0183","BK0060","BK0187","BK0012","BK1515","BK0188","600196","02196","BK0028","BK1593"],"gpt_icon":0},{"id":"2528978807","title":"康哲藥業2024年淨利降超30% 高管逆勢漲薪","url":"https://stock-news.laohu8.com/highlight/detail?id=2528978807","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528978807?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 18:38","pubTimestamp":1744886335,"startTime":"0","endTime":"0","summary":"康哲药业（00867）2024年营收74.69亿元，同比下滑6.8%；净利润16.2亿元，同比下降32.3%——这是其连续第二年营收净利双降。细观年报，一边是集采冲击下的现金流“失血”，另一边则是创新药管线“蓄势待发”。这家老牌药企的转型之路，像极了医药行业的“缩影”：在政策与市场的夹缝中，左手求生，右手赌未来。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504173380076279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999015952.SGD","SG9999015986.USD","BK1191","IE00BYV24P56.USD","SG9999004220.SGD","SG9999015945.SGD","BK1593","IE00BMCWC346.EUR","00867","SG9999015978.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2528794448","title":"每日賣空追蹤 | 三生製藥 04月17日賣空量成交127.3萬股，賣空比例為4.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528794448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528794448?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 18:19","pubTimestamp":1744885153,"startTime":"0","endTime":"0","summary":"三生制药北京时间04月17日，跌0.83%，卖空量成交127.3万股，较上一交易日减少69.31%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417181914a6bdcca0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417181914a6bdcca0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","BK1583","01530"],"gpt_icon":0},{"id":"2528799938","title":"現代牙科(03600)4月17日斥資42.02萬港元回購10萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2528799938","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528799938?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 18:01","pubTimestamp":1744884065,"startTime":"0","endTime":"0","summary":"智通财经APP讯，现代牙科(03600)发布公告，于2025年4月17日斥资42.02万港元回购股份10万股，每股回购价格为4.19-4.22港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1593","BK1100","03600"],"gpt_icon":0},{"id":"2528793957","title":"三生製藥抗癌新藥被納入突破性治療品種","url":"https://stock-news.laohu8.com/highlight/detail?id=2528793957","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528793957?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 17:12","pubTimestamp":1744881162,"startTime":"0","endTime":"0","summary":"三生制药发布公告，宣布其自主研发的抗VEGF/PD-1双特异性抗体药物707注射液于2025年4月17日获得国家药品监督管理局纳入突破性治疗品种，适应症为一线治疗PD-L1表达阳性的局部晚期或转移性非小细胞肺癌。该药物的新药临床试验申请也获得了美国食品药品监督管理局的批准。根据公告，CDE将对纳入突破性治疗品种的药品提供政策支持，优先配置资源进行沟通交流，并加快药品上市进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417172644a45c4a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417172644a45c4a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1593","BK1583","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":116,"code":"91000000","status":"200"}]}}